Press Releases

Clene Announces Updated VISIONARY-MS Phase 2 Trial Data Presented at 2023 ACTRIMS Forum Show CNM-Au8® Demonstrated Significant Improvements in Clinical Outcomes, Brain Structure, and Visual System
Positive clinical results demonstrated in stable relapsing multiple sclerosis patients adjunctive to immunomodulatory   disease modifying therapy was previously reported Updated Visual Evoked Potential (VEP) findings provide evidence of improved information signaling from the eye to the brain’s
February 27, 2023
PDF Version
Displaying 11 - 13 of 13